Sales 2024 * | 46.21B 49.59B | Sales 2025 * | 49.86B 53.51B | Capitalization | 114B 122B |
---|---|---|---|---|---|
Net income 2024 * | 6.86B 7.36B | Net income 2025 * | 8.56B 9.18B | EV / Sales 2024 * | 2.59 x |
Net Debt 2024 * | 5.76B 6.18B | Net Debt 2025 * | 2.07B 2.22B | EV / Sales 2025 * | 2.33 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
13.3
x | Employees | - |
Yield 2024 * |
4.15% | Yield 2025 * |
4.46% | Free-Float | 87.01% |
Latest transcript on Sanofi SA
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 19-08-31 |
Madeleine Roach
COO | Chief Operating Officer | 39 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 14-04-30 |
Lise Kingo
BRD | Director/Board Member | 62 | 20-04-27 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 20-05-21 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |